Close Menu

Time To Start

In a recent interview with Forbes' Matthew Herper, Dendreon's retiring chief scientist, David Urdal, weighs in on the lack of new drugs in the past few years. When Herper asks him why the drug business is "in such a profound innovation drought," Urdal says the dynamics of drug innovation have changed from when he began to work in the biotech industry.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.